About: Baystate Medical Center

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Baystate Medical Center Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

US medical facility; part of Baystate Health

Attributes	Values
rdf:type	Item
description	americká firma (cs) شركة أمريكية (ar) bedrijf uit Verenigde Staten van Amerika (nl) US medical facility; part of Baystate Health (en)
rdfs:label	Baystate Medical Center (en) Baystate Medical Center (fr)
skos:prefLabel	Baystate Medical Center (en) Baystate Medical Center (fr)
name	Baystate Medical Center (en) Baystate Medical Center (fr)
ROR ID	wds:Q4874851-2FD4EE87-1499-419A-8AF9-229A886CF3F3
ROR ID	01q2nz307
instance of	wds:Q4874851-33D3322D-4CCA-4210-A327-BF020BBA9A55 wds:Q4874851-7de98b47-4a08-4eca-b979-d80abc29b3b9
part of	wds:Q4874851-2c9b1623-4465-8637-bead-37f789bf45d1
instance of	business medical facility
part of	Baystate Health
country	wds:Q4874851-285088F3-3D51-4AC7-B574-55CAC715B874
country	United States of America
Ringgold ID	wds:Q4874851-614D796D-7A8E-42CF-BF29-DC2C50B729B5
Ringgold ID	21645
headquarters location	wds:Q4874851-A9B8BFFA-B2BE-4886-AFF8-9622DB1F7BEA
headquarters location	Springfield
skos:altLabel	Springfield Hospital (en)
OpenAlex ID	wds:Q4874851-D9D29C02-A231-4F7A-8A0C-82C8661AF2A9
GeoNames ID	wds:Q4874851-83DE6032-AE85-4D49-8982-D5994A09356F
Crunchbase organization ID	wds:Q4874851-88AD947B-A27D-4880-BEB6-47145931DFAB
ISNI	wds:Q4874851-6804D078-E8CE-4687-8B78-48668504AD5A
VIAF ID	wds:Q4874851-D849190C-CE6A-4D94-AAF1-7942056D7DB6
Library of Congress authority ID	wds:Q4874851-EF814D06-2615-4988-ACB4-B8438F60487C
Microsoft Academic ID	wds:Q4874851-9AF33F16-BAA6-4543-8124-866701057801
WorldCat Identities ID (superseded)	wds:Q4874851-F942F6DF-8456-4A22-8826-C4A2337D6B5C
official website	wds:Q4874851-1779D79E-9657-4ED8-A831-BCC09D2EDC5D
GeoNames ID	http://sws.geonames.org/4951812/
VIAF ID	http://viaf.org/viaf/156006926
Library of Congress authority ID	http://id.loc.gov/authorities/names/n85188902
Microsoft Academic ID	https://makg.org/entity/1338449461
OpenAlex ID	I1338449461
GeoNames ID	4951812
Crunchbase organization ID	baystate-health
ISNI	000000040433813X
VIAF ID	156006926
Library of Congress authority ID	n85188902
Microsoft Academic ID	1338449461
WorldCat Identities ID (superseded)	lccn-n85188902
official website	http://baystatehealth.org/
GRID ID	wds:Q4874851-FBA6CB9B-7C48-46D2-B6FC-E3B7A5586D2E
GRID ID	grid.281162.e
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q4874851
is has part(s) of	Baystate Health
is has part(s) of	wds:Q4874850-bd74a981-4827-07c0-658f-74a658d07788
is research site of	Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE) Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma SPIRIT Small Vessel Registry Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction - Safety and Feasibility Study Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot Study Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Improving Outcomes in Neonatal Abstinence Syndrome Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer Third International Study on Mechanical Ventilation The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD) Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Vinorelbine in Treating Children With Recurrent or Refractory Cancers Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma S1406 Phase II Study of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer Lifestyle Intervention in Overweight and Obese Pregnant Hispanic Women Pharmacokinetics of Oral Thiamine Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial) Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Anti-TF Antibody (ALT-836) to Treat Septic Patients With Acute Lung Injury or Acute Respiratory Distress Syndrome Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) Nivolumab and Ipilimumab With or Without Sargramostim in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Bispectral Index Monitoring During Testing in the Electrophysiology Lab Thiamine and Acute Decompensated Heart Failure: Pilot Study Red Cell Storage Duration Study Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. REASSURE AV Registry

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software